1 Min Read
Nov 5 (Reuters) - Novartis AG:
* NOVARTIS CFO SAYS - EXPECTS RESEARCH AND DEVELOPMENT COSTS TO DECLINE OVER TIME TO AROUND 20 PERCENT OF SALES Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.